ID   MeCo 05
AC   CVCL_3403
SY   MECO
DR   CLDB; cl7181
DR   ICLC; HTL07001
DR   Wikidata; Q54905003
RX   PubMed=23634660;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ICLC=HTL07001
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 13
ST   D21S11: 29
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
RX   PubMed=23634660; DOI=10.1186/1479-5876-11-108; PMCID=PMC3663700;
RA   Laurent, Stefania
RA   Queirolo, Paola
RA   Boero, Silvia
RA   Salvi, Sandra
RA   Piccioli, Patrizia
RA   Boccardo, Simona
RA   Minghelli, Simona
RA   Morabito, Anna
RA   Fontana, Vincenzo
RA   Pietra, Gabriella
RA   Carrega, Paolo
RA   Ferrari, Nicoletta
RA   Tosetti, Francesca Isabella
RA   Chang, Lung-Ji
RA   Mingari, Maria Cristina
RA   Ferlazzo, Guido
RA   Poggi, Alessandro
RA   Pistillo, Maria Pia
RT   "The engagement of CTLA-4 on primary melanoma cell lines induces
RT   antibody-dependent cellular cytotoxicity and TNF-alpha production.";
RL   J. Transl. Med. 11:108.1-108.13(2013).
//